FOI release

Freedom of Information request on the regulatory approval of the COVID-19 Pfizer vaccine (FOI 22/462)

Published 31 May 2022

FOI 22/462

21st February 2022

Dear

Thank you for your email.

This information would be exempt under Section 41 and Section 43 of the FOI Act. We do not give away commercial secrets concerning the manufacture and control of any medicinal product or its ingredients. The levels of ingredients, impurities and degradants are controlled in all authorised medicinal products so that they are safe. Further, when applying the public interest test for S43, it should be noted that no evidence of carcinogens have been found in any of the authorised vaccines to substantiate the claims being made.

If you have a query about the information provided, please reply to this email.

If you disagree with how we have interpreted the Freedom of Information Act 2000 in answering your request, you can ask for an internal review. Please reply to this email, within two months of this reply, specifying that you would like an Internal Review to be carried out.

Please remember to quote the reference number above in any future communications.

If you were to remain dissatisfied with the outcome of the internal review, you would have the right to apply directly to the Information Commissioner for a decision. Please bear in mind that the Information Commissioner will not normally review our handling of your request unless you have first contacted us to conduct an internal review. The Information Commissioner can be contacted at:

Information Commissioner’s Office
Wycliffe House
Water Lane
Wilmslow
Cheshire
SK9 5AF

Yours sincerely

MHRA Customer Experience Centre